Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International Inc. extended their recent ...
Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...